Brief Description
Azalea Therapeutics is an early-stage biotech startup on a mission to revolutionize genomic medicines. By designing vehicles that enable cell-specific delivery inside the body, the company aims to unlock precision therapeutics for genetic diseases and unleash the promise of cellular-based therapies. The company's co-founders include Jennifer Doudna, a Nobel Laureate in Chemistry and UC Berkeley Professor of Biochemistry, Biophysics and Structural Biology, with Postdocs and a PhD student from her lab: CEO/CSO Jennifer Hamilton (PhD, 2018-2023); Founding Scientist Connor Tsuchida (Postdoc, 2023); and Foundational Scientist Abdullah Muhammad Syed (Postdoc, 2020-2023).
Timeline
- 2023. Company founded
Inventors
Connor Tsuchida, Jennifer Doudna, Jennifer Hamilton